Post-marketing Surveillance for the Clinical Safety and Effectiveness of Eribulin Mesylate in Patients With Inoperable or Recurrent Breast Cancer (Study HAL01S)
Clinical trial NCT01463891 · COMPLETED
Trial details
- NCT number
- NCT01463891
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-07-19
- Primary completion
- 2012-12-26
- Enrollment
- 963
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.